Skip to main content
. 2017 Aug 21;7:8363. doi: 10.1038/s41598-017-08743-y

Figure 4.

Figure 4

The ELISA assay of the interaction between TLR2 protein and LipL32 variants. (A) The interaction of TLR2 protein and LipL32 truncated variants. The protein concentration of LipL32 and TLR2 protein were 1 µM. BSA and Pam3CSK4 were served as negative and positive controls. WT + PK indicated the LipL32WT pretreated with proteinase K for ELISA assay. (B) The interaction of TLR2 protein and LipL32 point mutation variants. (C) The dose dependent ELISA of the interaction between LipL32ΔCenα3 variant and TLR2 protein. ○, LipL32WT in the presence of 1 µM Ca2+; ●, LipL32WT in the presence of 1 µM EGTA; ▼, LipL32ΔCenα3 in the presence of 1 µM Ca2+; △, LipL32ΔCenα3 in the presence of 1 µM EGTA. (D) The dose dependent ELISA of the interaction between LipL32 point mutation variants and TLR2. ○, D195A variant in the presence of 1 µM Ca2+; ●, D195A variant in the presence of 1 µM EGTA; ▼, D196A variant in the presence of 1 µM Ca2+; Δ, D196A in the presence of 1 µM EGTA. *p < 0.05; **p < 0.01; ***p < 0.001.